Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Queensland Health
Cipla
Daiichi Sankyo
Covington
Colorcon
US Department of Justice
Cerilliant
Dow

Generated: April 19, 2018

DrugPatentWatch Database Preview

Alvogen Malta Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN MALTA, and what generic and branded alternatives to ALVOGEN MALTA drugs are available?

ALVOGEN MALTA has twenty-seven approved drugs.



Summary for Alvogen Malta
US Patents:0
Tradenames:25
Ingredients:22
NDAs:27

Drugs and US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta RIVASTIGMINE rivastigmine FILM, EXTENDED RELEASE;TRANSDERMAL 204403-002 Sep 3, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 202116-001 Dec 30, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 202116-003 Dec 30, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,717,655 ➤ Try a Free Trial
Alvogen Malta SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,839,574 ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 3,934,032 ➤ Try a Free Trial
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-001 Jan 5, 1996 5,637,320 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Moodys
McKinsey
Accenture
Harvard Business School
Merck
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.